Cargando…
Targeting primary and metastatic uveal melanoma with a G protein inhibitor
Uveal melanoma (UM) is the most common intraocular tumor in adults. Nearly half of UM patients develop metastatic disease and often succumb within months because effective therapy is lacking. A novel therapeutic approach has been suggested by the discovery that UM cell lines driven by mutant constit...
Autores principales: | Onken, Michael D., Makepeace, Carol M., Kaltenbronn, Kevin M., Choi, Joelle, Hernandez-Aya, Leonel, Weilbaecher, Katherine N., Piggott, Kisha D., Rao, P. Kumar, Yuede, Carla M., Dixon, Alethia J., Osei-Owusu, Patrick, Cooper, John A., Blumer, Kendall J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948511/ https://www.ncbi.nlm.nih.gov/pubmed/33577798 http://dx.doi.org/10.1016/j.jbc.2021.100403 |
Ejemplares similares
-
Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma
por: Onken, Michael D., et al.
Publicado: (2021) -
Protein Kinase Signaling Networks Driven by Oncogenic Gq/11 in Uveal Melanoma Identified by Phosphoproteomic and Bioinformatic Analyses
por: Onken, Michael D., et al.
Publicado: (2023) -
Uveal melanoma cells use ameboid and mesenchymal mechanisms of cell motility crossing the endothelium
por: Onken, Michael D., et al.
Publicado: (2021) -
Uveal Melanoma Cells Utilize a Novel Route for Transendothelial Migration
por: Onken, Michael D., et al.
Publicado: (2014) -
Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma
por: Yen, Matthew, et al.
Publicado: (2018)